Exponent, Inc. $EXPO Shares Acquired by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Posted by Francis Steltz on Sep 6th, 2026

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in shares of Exponent, Inc. (NASDAQ:EXPO – Free Report) by 160.5% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 271,842 shares of the business services provider’s stock after buying an additional 167,484 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in Exponent were worth $15,973,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in the company. Empowered Funds LLC acquired a new stake in shares of Exponent during the second quarter valued at about $558,000. Jefferies Financial Group Inc. acquired a new position in shares of Exponent in the second quarter worth about $3,928,000. Public Employees Retirement System of Ohio acquired a new position in shares of Exponent in the second quarter worth about $29,000. Capstone Investment Advisors LLC purchased a new position in Exponent in the second quarter valued at about $3,065,000. Finally, Corient Private Wealth LP purchased a new position in Exponent in the second quarter valued at about $265,000. Institutional investors and hedge funds own 92.37% of the company’s stock.

Insider Buying and Selling

In other Exponent news, CEO Catherine Corrigan sold 4,119 shares of Exponent stock in a transaction that occurred on Monday, June 15th. The stock was sold at an average price of $57.13, for a total value of $235,318.47. Following the completion of the transaction, the chief executive officer directly owned 106,670 shares in the company, valued at $6,094,057.10. The trade was a 3.72% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.70% of the stock is currently owned by insiders.

Exponent Price Performance

EXPO stock opened at $68.35 on Friday. The firm has a market cap of $3.25 billion, a price-to-earnings ratio of 30.65 and a beta of 0.68. Exponent, Inc. has a 1-year low of $51.91 and a 1-year high of $81.95. The firm has a fifty day moving average price of $65.52 and a two-hundred day moving average price of $64.46.

Exponent (NASDAQ:EXPO – Get Free Report) last posted its quarterly earnings results on Thursday, July 30th. The business services provider reported $0.60 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.55 by $0.05. Exponent had a net margin of 17.67% and a return on equity of 31.48%. The company had revenue of $171.61 million for the quarter, compared to the consensus estimate of $144.99 million. During the same period last year, the firm posted $0.52 EPS. The company’s revenue for the quarter was up 12.0% on a year-over-year basis. As a group, analysts expect that Exponent, Inc. will post 2.31 EPS for the current fiscal year.

Exponent Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 18th. Shareholders of record on Friday, September 4th will be issued a $0.31 dividend. The ex-dividend date of this dividend is Friday, September 4th. This represents a $1.24 dividend on an annualized basis and a yield of 1.8%. Exponent’s dividend payout ratio (DPR) is currently 55.61%.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on EXPO shares. UBS Group set a $72.00 price objective on Exponent and gave the stock a “neutral” rating in a report on Friday, July 31st. JPMorgan Chase & Co. increased their target price on Exponent from $80.00 to $90.00 and gave the company an “overweight” rating in a research note on Friday, July 31st. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Exponent in a research report on Friday, July 17th. Two research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat.com, Exponent presently has an average rating of “Moderate Buy” and an average target price of $81.00.

Read Our Latest Stock Report on Exponent

Exponent Profile

(Free Report)

Exponent, Inc (NASDAQ: EXPO) is an engineering and scientific consulting firm that offers multidisciplinary analysis and advisory services to clients across a range of industries. The company’s expertise spans mechanical, materials and corrosion engineering, civil and structural engineering, electrical engineering, industrial hygiene, toxicology and health sciences, and failure analysis. Exponent provides support for product design, performance evaluation, litigation consulting, and regulatory compliance, helping manufacturers, insurers, law firms and government agencies address complex technical challenges.

Founded in 1967 in Menlo Park, California, Exponent has grown from a small failure-analysis laboratory into a global consulting practice.